drugset

drugset / Trial / NCT02035501

Treatment of TNNT1-Myopathy With L-Tyrosine.

NCT02035501 ↗

Phase 2 Unknown 10 enrolled Hadassah Medical Organization

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of the study is to investigate if treatment with L-Tyrosine improves selected outcome measures of TNNT1 myopathy.

Timeline

Start: 2014-01
Primary completion: 2015-01
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	L-Tyrosine	Unknown	—	—

Indications